Portola Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 45 U.S.-traded ETFs. PTLA has around 7.1M shares in the U.S. ETF market. The largest ETF holder of PTLA is the iShares Russell 2000 ETF (IWM), with approximately 1.70M shares. Investors may also find of interest that the ETF with the largest allocation to PTLA stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.64%. On average, U.S. ETFs allocate 0.24% of PTLA to their portfolios.
Additionally, PTLA is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PTLA as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.